Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance - Test2 - elhamkhani - TriplyDB

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

http://www.wikidata.org/entity/Q36926651

about

Beta-thalassemia Splenectomy for people with thalassaemia major and intermedia Splenectomy for people with thalassaemia major or intermedia Current and future alternative therapies for beta-thalassemia major Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathies Role of cardiac MRI in the assessment of nonischemic cardiomyopathies Recent advances in cardiac magnetic resonance.What Unrelated Hematopoietic Stem Cell Transplantation in Thalassemia Taught us about Transplant Immunogenetics Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial Haemoglobin disorders in Australia: where are we now and where will we be in the future?Practical applications of cardiovascular magnetic resonance.Review of Journal of Cardiovascular Magnetic Resonance 2012.High spatial resolution and temporally resolved T2* mapping of normal human myocardium at 7.0 Tesla: an ultrahigh field magnetic resonance feasibility study.Review of Journal of Cardiovascular Magnetic Resonance 2011.Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies.Toward cardiovascular MRI at 7 T: clinical needs, technical solutions and research promises Review of Journal of Cardiovascular Magnetic Resonance 2009 Cardiac resynchronization therapy guided by cardiovascular magnetic resonance Evidence for a novel mechanism independent of myocardial iron in β-thalassemia cardiac pathogenesis.Pregnancy in beta-thalassemia intermedia: 20-year experience of a Greek thalassemia center.Patient Involvement as Experts in the Development and Assessment of a Smartphone App as a Patient Education Tool for the Management of Thalassemia and Iron Overload Syndromes.Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel.Pregnancy and beta-thalassemia: an Italian multicenter experience.Complications and treatment of patients with β-thalassemia in France: results of the National Registry.Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload.T2 mapping and T2* imaging in heart failure Iron and atherosclerosis: nailing down a novel target with magnetic resonance.Pregnancy Outcomes in Women with Homozygous Beta Thalassaemia: A single-centre experience from Oman Calibration of myocardial T2 and T1 against iron concentration.Education and employment status of children and adults with thalassemia in North America.International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers.Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit.Optimal method for early detection of cardiac disorders in thalassemia major patients: magnetic resonance imaging or echocardiography?Cardiovascular magnetic resonance T2* for tissue iron assessment in the heart.Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance Value of black blood T2* cardiovascular magnetic resonance.

P2860

Q21202886-4B51DC7F-3143-4E72-8D58-C4161AEE4C15 Q24202998-AED0339F-03DE-4997-9B73-DBD070B5AA37 Q26471468-9C53F9A6-0401-476B-9DBD-59F68063E6B9 Q26750906-6E4662F9-CC59-4249-9B54-0AA2E022DB4F Q26765173-FEA93303-4263-4269-A578-C388A3F7C0F7 Q26998997-6B1CC270-6009-4CD5-9E8A-C78CF5F8A4F1 Q28066746-8758D8C5-8B6E-4F89-8D3F-5398745AA6B4 Q28075219-2F8F2C82-6F2F-4152-9D94-D9651EED0A67 Q28387402-F88595B4-3A2D-4DA0-B1DC-FD7F285B5AE1 Q28552171-E0B95A65-379D-4954-9F90-605B78915D35 Q30251663-595261A4-1643-4742-8277-904EA858F29C Q30381191-81A1526E-ABD0-46F9-B89E-9B2EF6D331A8 Q30446298-97DC4569-8D19-4C85-9B76-298B06885C79 Q30459820-813E71D1-3DAA-4EBC-A3DE-D1EFB933DD5C Q30459937-F8AE076D-4D97-413C-BE69-DBEDE9FA181F Q30463822-B68ED096-34D5-40F3-8AD4-D69CDE02F726 Q30476882-69E2B1A6-AFF6-4CF3-A6D5-3CBDC9808EB8 Q30484444-27C5A2E3-6873-4580-896A-82DE4888DF6A Q30497515-51428299-6423-4BAC-ACD5-07913E733BA3 Q31110125-CE6B0905-212D-494C-A370-176C015B4A24 Q33415683-99C65C70-4225-44BF-9981-737D41E1CA87 Q33450262-159EA8AB-3D7B-4DC4-934A-05D43774D5CD Q33558770-019370F3-B725-48B2-9677-5D80E62CD2F8 Q33707385-4CED5EAF-4D45-45C9-8E99-A1958CBA966E Q33829058-3D601E6D-9F01-45BF-9E9A-C258F74335A1 Q33843186-305A0A9F-1B4C-46EC-B78A-967C7C80850D Q33844225-081D2FD6-D505-4EA6-A59E-52F11FEAC396 Q33911344-F545CB0B-6FF0-4BA9-9C86-939625FD9D2E Q33982929-6070E36E-FEA4-43B8-B504-1367F4589D2C Q34091560-FFCBBB8D-70C0-4027-909D-62DEC33376E5 Q34101401-D3BE0D0C-A034-4FE4-B564-DBF88D0D8AB3 Q34158260-33790742-753C-453B-BDC3-F5E95AB997E6 Q34269245-D81C4348-68D0-4424-BAF2-4FBB1EA50872 Q34302477-C59DBC6C-01AC-4F08-B8B3-F30E0CC77EBE Q34422736-642C718F-D9A5-4911-B180-7ADCCFEDFE43 Q34449867-47C5C188-D1D5-453F-B6D2-6FB3CEB5FDBE Q34451519-69DABFB5-050E-42F6-A605-C42BB41A76D5 Q34451527-0AAAB577-26EE-4952-8413-48D92D15A1CD Q34515540-A8801A12-4770-42BC-B620-3C679DCE7741 Q34706719-ED1B3D1B-90DF-499A-A0C0-BB298859B32A

P2860

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

http://www.wikidata.org/entity/Q36926651

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Improved survival of thalassae ...... diovascular magnetic resonance

@en

type

label

Improved survival of thalassae ...... diovascular magnetic resonance

@en

prefLabel

Improved survival of thalassae ...... diovascular magnetic resonance

@en

P1433

Q36926651-CFD92598-0F91-4C88-BEFD-1F86E54B358E

P1476

Q36926651-C4A025DC-470D-4FDF-8C18-1819B35505A2

P2093

Q36926651-137BE4D6-0E1D-408B-8BD6-5C83E3E5158D

Q36926651-8281B632-053D-43AA-ABBB-766B807BA358

Q36926651-984C5267-57CC-48B5-B71B-CD28A8B298B9

Q36926651-D0D9A78C-D82F-4DAB-B3CA-AE1C5BA87053

Q36926651-EDA2E366-9B69-4DA4-A374-E211CC4B9CB8

P2860

Q36926651-0D8C465E-0674-4ABB-95C5-67830164F453

Q36926651-11730B91-71F2-4C46-A0F3-C542C28BB0D0

Q36926651-146EBD0E-81AF-42C2-AB84-A483AA366468

Q36926651-1C2F033D-A0B5-47C0-8EBA-7FA4A57CE557

Q36926651-1EF23636-F478-4DD8-BC83-96AC27987A69

Q36926651-276B0B37-6B93-4E82-837A-8976E28C8532

Q36926651-2B4017BE-703E-459C-85B9-BEDC624E0C74

Q36926651-30828BDA-CFCE-4937-B8FF-20590846C2E4

Q36926651-32C3FFB7-D6E8-43E2-804B-E544AF7BEA48

Q36926651-3E0E226A-8493-4624-A011-0C0A5BAB67A4

P2888

Q36926651-1F9C7F58-D82C-4BFA-9530-1469D69F8F98

P304

Q36926651-FB885489-0CE3-4C2D-8F7B-699EAADD36F5

P31

Q36926651-8E7486B0-A6DD-42D8-8E82-22DD614591CA

P356

Q36926651-E4338E66-7848-42F8-8CDE-EBBCF60D7066

P478

Q36926651-B6D43926-A929-4130-883B-57B56DCA80BA

P50

Q36926651-483FB660-7B8D-4B6D-9C9A-332D90DBBD71

Q36926651-FC43DEC9-D55D-47A6-9B63-257D90DF54CC

P577

Q36926651-15FA00A3-AB62-43E4-8F22-E30C2E5E3021

P6179

Q36926651-F2CCACC0-708F-42AB-BE4B-9FD7AAED1A84

P698

Q36926651-9323FFB2-DF7D-41BF-8F98-6C8F3BC82F02

P921

Q36926651-EC73497C-1FDB-43E9-A17A-90366DD54D31

P932

Q36926651-A227A0CC-3A65-490B-B2F2-D6FFF4C1A4FC

P356

1532-429X-10-42

P1433

Journal of Cardiovascular Magnetic Resonance

P1476

Improved survival of thalassae ...... diovascular magnetic resonance

@en

P2093

Bernadette Modell

http://www.w3.org/2001/XMLSchema#string

David Ingram

http://www.w3.org/2001/XMLSchema#string

Maren Khan

http://www.w3.org/2001/XMLSchema#string

Mark A Westwood

http://www.w3.org/2001/XMLSchema#string

Matthew Darlison

http://www.w3.org/2001/XMLSchema#string

P2860

Deferiprone therapy for transfusional iron overload

A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance

Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.

Comparison of the effects of deferiprone versus deferoxamine on growth and virulence of Yersinia enterocolitica.

Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.

Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron.

Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis.

Microbial iron-chelators and their action on Klebsiella infections in the skin of guinea-pigs

Multi-center transferability of a breath-hold T2 technique for myocardial iron assessment.

P2888

1532-429x-10-42

P304

42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1532-429X-10-42

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Bernadette Modell

P577

2008-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1048144700

http://www.w3.org/2001/XMLSchema#string

P698

18817553

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio

P932

2563008

http://www.w3.org/2001/XMLSchema#string